Clinical Trial: Molecular Imaging of EpCam Expression in Breast Cancer Using [99mTc]Tc-DARPinEc1-G3C

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784660) titled 'Molecular Imaging of EpCam Expression in Breast Cancer Using [99mTc]Tc-DARPinEc1-G3C' on Aug. 20.

Brief Summary: The study should evaluate distribution of [99mTc]Tc-DARPinEc1-G3C in patients with primary Triple negative and Luminal breast cancer.

The primary objective are:

1. To assess distribution of [99mTc]Tc-DARPinEc1-G3C in normal tissues and in tumors over time;

2. To evaluate dosimetry of [99mTc]Tc-DARPinEc1-G3C in breast cancer patients;

3. To obtain initial information concerning safety and tolerability of [99mTc]Tc-DARPinEc1-G3C in breast cancer patients after single intravenous injection:

The secondary objective are:...